Putnam Investments’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-270,000
Closed -$8.57M 789
2021
Q1
$8.57M Buy
+270,000
New +$7.92M 0.01% 403
2015
Q4
Sell
-41,526
Closed -$7.41M 1447
2015
Q3
$7.41M Sell
41,526
-300
-0.7% -$70K 0.02% 527
2015
Q2
$9.29M Sell
41,826
-41,626
-50% -$9.23M 0.02% 504
2015
Q1
$16.6M Sell
83,452
-2,525
-3% -$448K 0.03% 384
2014
Q4
$12.3M Sell
85,977
-67,278
-44% -$9.05M 0.03% 446
2014
Q3
$20.1M Buy
153,255
+40,312
+36% +$4.81M 0.04% 327
2014
Q2
$14.2M Buy
+112,943
New +$14.4M 0.03% 395
2014
Q1
Sell
-3,942
Closed -$463K 1482
2013
Q4
$463K Hold
3,942
﹤0.01% 1361
2013
Q3
$411K Sell
3,942
-60,157
-94% -$5.86M ﹤0.01% 1370
2013
Q2
$5.52M Buy
+64,099
New +$5.05M 0.02% 638

Other funds holding BHC

Putnam Investments's BHC Position: Q2 2021 in Review

Putnam Investments sold out of Bausch Health (BHC) in Q2 2021, closing a stake of 270,000 shares — an estimated $8.57M sold.

Putnam Investments first reported a position in BHC in Q2 2013 and held it in 10 quarters. The position peaked at $20.1M in Q3 2014. 357 funds tracked by Wall St. Rank hold BHC as of Q2 2021.

  • Putnam Investments reported no remaining Bausch Health position as of Q2 2021 after selling out during the quarter.
  • Putnam Investments sold 270,000 Bausch Health shares in Q2 2021, an estimated $8.57M.
  • Putnam Investments first reported a position in Bausch Health in Q2 2013 and held it in 10 quarters.
  • Putnam Investments's Bausch Health position peaked at $20.1M in Q3 2014.
  • 357 funds tracked by Wall St. Rank held Bausch Health as of Q2 2021.

Based on Putnam Investments's 13F filing for Q2 2021, filed 16 Aug 2021.